C
FOLD

Covestor’s Amicus Therapeutics FOLD Stock Holding History

Covestor’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25K Sell
1,745
-5,403
-76% -$77.5K 0.02% 1018
2025
Q4 		$102K Sell
7,148
-6,079
-46% -$59.7K 0.05% 566
2025
Q3 		$104K Buy
13,227
+3,846
+41% +$27.4K 0.06% 560
2025
Q2 		$54K Buy
9,381
+3,363
+56% +$21.7K 0.03% 866
2025
Q1 		$49K Buy
6,018
+1,693
+39% +$15.7K 0.03% 851
2024
Q4 		$41K Buy
4,325
+2,312
+115% +$24K 0.03% 926
2024
Q3 		$22K Buy
2,013
+1
+0% +$11 0.01% 1176
2024
Q2 		$20K Sell
2,012
-1,526
-43% -$15.7K 0.01% 1199
2024
Q1 		$42K Buy
3,538
+881
+33% +$11.3K 0.03% 948
2023
Q4 		$38K Buy
2,657
+1,686
+174% +$19.1K 0.03% 964
2023
Q3 		$12K Buy
971
+624
+180% +$8.05K 0.01% 1324
2023
Q2 		$4K Sell
347
-1,776
-84% -$21.1K ﹤0.01% 1722
2023
Q1 		$24K Buy
2,123
+2,101
+9,550% +$25.9K 0.02% 939
2022
Q4 		$0 Sell
22
-2,022
-99% -$22.8K ﹤0.01% 2232
2022
Q3 		$21K Buy
2,044
+2,008
+5,578% +$22.4K 0.02% 977
2022
Q2 		$0 Sell
36
-10
-22% -$82 ﹤0.01% 2071
2022
Q1 		$0 Sell
46
-11
-19% -$103 ﹤0.01% 2220
2021
Q4 		$1K Buy
+57
New +$635 ﹤0.01% 1749

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Covestor's FOLD Position: Q1 2026 in Review

Covestor reduced its Amicus Therapeutics (FOLD) stake by 76% in Q1 2026, selling an estimated $77.5K and leaving 1,745 shares worth $25K. The position accounts for 0.02% of the portfolio, ranked #1018.

Covestor first reported a position in FOLD in Q4 2021 and has held it in 18 quarters since. The position peaked at $104K in Q3 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Covestor held 1,745 shares of Amicus Therapeutics worth $25K as of Q1 2026.
  • Covestor sold 5,403 Amicus Therapeutics shares in Q1 2026, an estimated $77.5K.
  • Amicus Therapeutics made up 0.02% of Covestor's portfolio in Q1 2026, its #1018 holding.
  • Covestor first reported a position in Amicus Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Amicus Therapeutics position peaked at $104K in Q3 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.